Programmed Cell Death Ligand 1 Expression in Cytological and Surgical Non–Small Cell Lung Cancer Specimens in Association with EGFR Mutation and Overall Survival: A Single-Institution Experience

Objective: The aim of this study was to evaluate programmed cell death ligand-1 (PD-L1) expression and the relationship between driver mutations and survival analysis in advanced-stage non-small cell lung carcinoma (NSCLC). Material and Method: A total of 122 advanced-stage NSCLC patients were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayman Gokal, Elif, Vardar Aker, Fugen, Kus Sılav, Zuhal, Oven, Bala Basak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of Turkish Pathology Societies 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508421/
https://www.ncbi.nlm.nih.gov/pubmed/35642342
http://dx.doi.org/10.5146/tjpath.2022.01572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508421/
https://www.ncbi.nlm.nih.gov/pubmed/35642342
http://dx.doi.org/10.5146/tjpath.2022.01572

Ejemplares similares